Association between inflammation and cardiac geometry in chronic kidney disease: Findings from the CRIC study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Gupta, Jayanta ^a   Dominic, Elizabeth A ^b   Fink, Jeffrey C ^c   Ojo, Akinlolu O ^d   Barrows, Ian R ^b   Reilly, Muredach P ^e   Townsend, Raymond R ^e   Joffe, Marshall M ^e   Rosas, Sylvia E ^f   Wolman, Melanie ^e   Patel, Samir S ^g   Keane, Martin G ^h   Feldman, Harold I ^e   Kusek, John W ⁱ   Raj, Dominic S ^g   Appel, Lawrence J ^j   Go, Alan S ^j   He, Jiang ^j   Lash, James P ^j   Rahman, Mahboob ^j  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; RACE; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; AGED; BLOOD; CARDIAC MUSCLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84929353620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124772     Document Type: Article

References (43)

1. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B et al. (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498. PMID: 15086493
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352. PMID: 1825164
3. Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084. PMID: 11316868
4. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408. doi: 10.1172/JCI46122 PMID: 21985788
5. Fredj S, Bescond J, Louault C, Delwail A, Lecron JC, Potreau D (2005) Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J Cell Physiol 204: 428-436. PMID: 15717324
6. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL (1997) Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252. PMID: 9054856
7. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M et al. (2012) Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile. Clin J Am Soc Nephrol 7: 1938-1946. doi: 10.2215/CJN.03500412 PMID: 23024164
8. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE et al. (2012) Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD. J Am Soc Nephrol 23: 1725-1734. PMID: 22935481
9. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J et al. (2003) The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14: S148-S153. PMID: 12819321
10. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254. PMID: 16908915
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463. PMID: 16376782
12. Fox ER, Taylor HA Jr, Benjamin EJ, Ding J, Liebson PR, Arnett D et al. (2005) Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke 36: 546-550. PMID: 15662040
13. de SG, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056-1062. PMID: 7897116
14. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22: 107-133. doi: 10.1016/j.echo.2008.11.023 PMID: 19187853
15. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR et al. (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359: 2456-2467. doi: 10.1056/NEJMoa0805450 PMID: 19001508
16. Rao M, Guo D, Perianayagam MC, Tighiouart H, Jaber BL, Pereira BJ et al. (2005) Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 45: 324-333. PMID: 15685511
17. Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D et al. (2011) CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 32: 84-92. doi: 10.1093/eurheartj/ehq371 PMID: 20943670
18. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL et al. (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865. PMID: 8981934
19. Wollert KC, Drexler H (2001) The role of interleukin-6 in the failing heart. Heart Fail Rev 6: 95-103. PMID: 11309528
20. Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A et al. (2014) Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring) 22: 1359-1366. doi: 10.1002/oby.20692 PMID: 24415732
21. Raj DSC, Dominic EA, Pai A, Osman F, Morgan M, Pickett G et al. (2005) Skeletal muscle, cytokines and oxidative stress in End-stage renal disease. Kidney Int 68: 2338-2344. PMID: 16221238
22. Mann DL (2003) Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol 65: 81-101. doi: 10.1146/annurev.physiol.65.092101.142249;092101.142249 [pii]. PMID: 12500970
23. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK (2002) C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144: 233-238. PMID: 12177639
24. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ et al. (2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68: 766-772. PMID: 16014054
25. Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES (2007) Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension 50: 723-728. PMID: 17635853
26. Monfared A, Salari A, Kazemnezhad E, Lebadi M, Khosravi M, Mehrjardi NK et al. (2013) Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients. Int Urol Nephrol 45: 1679-1686. doi: 10.1007/s11255-012-0375-x PMID: 23306861
27. Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F et al. (2009) Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol 20: 2651-2660. doi: 10.1681/ASN.2009060631 PMID: 19850955
28. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. Journal of the American Society of Nephrology 5: 2024-2031. PMID: 7579050
29. Kurdi M, Randon J, Cerutti C, Bricca G (2005) Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats. Mol Cell Biochem 269: 95-101. PMID: 15786720
30. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J et al. (2000) Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275: 29717-29723. PMID: 10843995
31. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. Journal of the American Society of Nephrology 7: 728-736. PMID: 8738808
32. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT et al. (2006) Systolic and diastolic heart failure in the community. JAMA 296: 2209-2216. PMID: 17090767
33. Oral H, Dorn GW, Mann DL (1997) Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 272: 4836-4842. PMID: 9030540
34. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A 86: 6753-6757. PMID: 2549546
35. Wu CK, Lee JK, Chiang FT, Yang CH, Huang SW, Hwang JJ et al. (2011) Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase. Crit Care Med 39: 984-992. doi: 10.1097/CCM.0b013e31820a91b9 PMID: 21263314
36. Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2: d12-d26. PMID: 9159205
37. Zoccali C, Tripepi G, Mallamaci F (2006) Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 17: S169-S173. 17/12-suppl-3/S169 [pii];doi: 10.1681/ASN.2006080910 PMID: 17130257
38. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ et al. (2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68: 766-772. PMID: 16014054
39. Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR et al. (2012) Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 21: 1167-1170. 1055-9965. doi: 10.1158/1055-9965.EPI-12-0110 PMID: 22564866
40. DeGoma EM, French B, Dunbar RL, Allison MA, Mohler ER III, Budoff MJ (2012) Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224: 274-279. doi: 10.1016/j.atherosclerosis.2012.07.017 PMID: 22846611
41. den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW (2006) The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant 21: 1588-1595. PMID: 16449284
42. Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR et al. (2011) Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 26: 1313-1318. doi: 10.1093/ndt/gfq557 PMID: 20846939
43. Snaedal S, Heimburger O, Qureshi AR, Danielsson A, Wikstrom B, Fellstrom B et al. (2009) Comorbidity and acute clinical events as determinants of CRP variation in hemodialysis patients: implications on patient survival. Am J Kidney Dis 53: -1033.